Axberi/Axberi HP (enoxaparin sodium solution for injection)
pCPA File Number:
22841
Negotiation Status:
Active Negotiation
Indication(s):
Thrombosis and cardiovascular conditions (prevention or treatment)
Sponsor/Manufacturer:
Baxter Corporation
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable